PDIA3 correlates with clinical malignant features and immune signature in human gliomas
Hao Zhang(Northwestern Polytechnical University), Hui Cao(Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Ziyu Dai(Central South University), Biqi Cui(Central South University), Fan Fan(Central South University), Zeyu Wang(Anhui University), Yulai Zhou(Central South University), Fangkun Liu(Central South University), Quan Cheng(Central South University)
Cited by 44
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535
Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions
|Journal of Hematology & Oncology|2020|400